Skip to content
Medical Supplies - Medical Equipment Store ⛰️ FREE SHIPPING ON ORDERS $100 OR MORE ⛰️ Toll Free: 1-888-687-4334
⛰️ FREE SHIPPING ON ORDERS $100 OR MORE ⛰️ Toll Free: 1-888-687-4334
  • Home
  • >
  • Bupivacaine Injections
  • >
  • Sensorcaine (Bupivacaine HCL) 0.25% with Epinephrine 1:200,000 (as bitartrate) Multi-Dose 50 mL Vials x 25/Tray

Sensorcaine (Bupivacaine HCL) 0.25% with Epinephrine 1:200,000 (as bitartrate) Multi-Dose 50 mL Vials x 25/Tray

Sold out
Original price $ 795.95
Current price $ 675.00
SKU 63323-0461-57
Medical Professional License Required to Unlock Account

(Note: We don’t Fill Personal Prescriptions)


How to Order:

Create an Account by Clicking “Login” on Top Right

Next email a copy of medical License to Sales@mountainside-medical.com

Time: License Approval in Usually Very Fast. Mostly likely 30 to 90 minutes if between Monday to Friday 8 am to 4 pm EST Business Days. Weekends will be approved on Monday.

Once Approved you will receive a Welcome email that your account is approved to purchase RX items.

Login and Start ordering.

If you should have any trouble or have a question, Please Call Toll-Free: 1-888-687-4334

All RX Deliveries are sent Signature Required

Sensorcaine® (bupivacaine HCl) injections are sterile isotonic solutions that contain a local anesthetic agent with and without epinephrine (as bitartrate) 1:200,000 and are administered parenterally by injection.

Local anesthetics block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone.

Systemic absorption of local anesthetics produces effects on the cardiovascular and central nervous systems (CNS). At blood concentrations achieved with normal therapeutic doses, changes in cardiac conduction, excitability, refractoriness, contractility, and peripheral vascular resistance are minimal. However, toxic blood concentrations depress cardiac conduction and excitability, which may lead to atrioventricular block, ventricular arrhythmias and cardiac arrest, sometimes resulting in fatalities. In addition, myocardial contractility is depressed and peripheral vasodilation occurs, leading to decreased cardiac output and arterial blood pressure. Recent clinical reports and animal research suggest that these cardiovascular changes are more likely to occur after unintended intravascular injection of bupivacaine. Therefore, incremental dosing is necessary.

Search Any Type of Product, Medication, or Alignment